Skip to main content
Contact Us
Subscribe
E-Edition
34°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Hemogenyx Pharmaceuticals PLC
Hemogenyx Pharmaceuticals PLC Announces New Custom R&D Facility Opening
July 13, 2022
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces Investor Webinar Recording
July 08, 2022
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces Change of Registered Office
July 01, 2022
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces Result of Annual General Meeting
June 30, 2022
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces Investor Webinar
June 27, 2022
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces Posting of Annual Report & Notice of AGM
June 07, 2022
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces Director/PDMR Shareholding
May 30, 2022
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces Immuno-Oncology Summit Europe Presentation
May 16, 2022
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC announces Final Results for the Year Ended 31 December 2021
April 29, 2022
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces CBR Update
March 16, 2022
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Hemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T pre-IND Meeting Request
February 16, 2022
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Exposures
COVID-19
Product Safety
Hemogenyx Pharmaceuticals Partnership with Selexis
January 12, 2022
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces H.C. Wainwright Bioconnect Conference
January 05, 2022
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces Hemo-CAR-T partnership with WuXi ATU
December 20, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T pre-IND Meeting Request
December 13, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Exposures
Product Safety
Hemogenyx Pharmaceuticals PLC Announces Convertible Loans Repayment
November 24, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces Lease of New York Mink Building Custom Laboratory
October 18, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals Announces CDX Licence Agreement
October 13, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Hemogenyx Pharmaceuticals PLC Announces Half-Year Report
September 30, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Hemogenyx Pharmaceuticals PLC Announces U.S. Approval of Monoclonal Antibody Patent
September 02, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Hemogenyx Pharmaceuticals PLC Announces Appointment of Business Advisor & Board Observer
July 26, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC announces Corporate Presentation
July 02, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces Result of Annual General Meeting
June 25, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces Changes to 2021 AGM Arrangements
June 15, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Exposures
COVID-19
Hemogenyx Pharmaceuticals PLC Announces
June 02, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Hemogenyx Pharmaceuticals PLC Announces Posting of Annual Report & Notice of AGM
May 28, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Exposures
COVID-19
Hemogenyx Pharmaceuticals PLC announces Total Voting Rights
May 28, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces Termination of Mint Facility; Admission of Shares
May 26, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces Director/PDMR Shareholding
May 19, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Hemogenyx Pharmaceuticals PLC Announces Loan Notes Sale & Conversion; Facility Terminated
May 18, 2021
From
Hemogenyx Pharmaceuticals PLC
Via
AccessWire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.